Sort Help
entries

Results

All (8)

All (8) ((8 results))

  • Table: 82-570-X
    Geography: Province or territory
    Description: The Health of Canadians report brings together important health data, both for the population overall and for specific groups, to provide a comprehensive portrait of population health and to shed light on health disparities. It includes key statistics on population health such as health outcomes (e.g., chronic conditions), health behaviours (e.g., exercise, nutrition), access to health care (e.g., unmet health care needs) and determinants of health (e.g., age, income).

    The Health of Canadians report is meant to be used by our federal, provincial and territorial partners, as well as health professionals, researchers, and policymakers across the country to inform policies and plans, leading to better, more equitable health outcomes for all Canadians.
    Release date: 2025-03-05

  • Public use microdata: 13-25-0011
    Description: This public use microdata file (PUMF) contains data for a wide variety of variables collected from the Canadian COVID-19 Antibody and Health Survey (CCAHS). The CCAHS collected information on the presence of chronic conditions, self-reported COVID-19 status, testing history, risk for infection, health behaviours and vaccination status. COVID-19 antibody seroprevalence laboratory data, and select demographic information are also available. Survey data were collected between April 2022 and August 2022, with the vast majority of collection occurring in May, June and July 2022.
    Release date: 2024-11-14

  • Table: 13-10-0867-01
    Geography: Canada
    Frequency: Occasional
    Description: Long term symptoms were defined as having COVID-19 symptoms at least 3 months after a self-reported positive test or suspected SARS-CoV-2 infection. Results on the status of long-term symptoms only included respondents for whom a period of three months separated their self-reported date of infection and the date they completed the questionnaire.
    Release date: 2023-08-03

  • Table: 13-10-0868-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.
    Release date: 2023-08-03

  • Public use microdata: 13-25-0009
    Description: This public use microdata file (PUMF) provides researchers access to data on the distribution of SARS-CoV-2 lineages detected in the Canadian provinces between May and September 2022. Samples were collected as part of the Canadian COVID-19 Antibody and Health Survey (CCAHS), Cycle 2. The PUMF file consists of a subset of participants of the CCAHS who submitted a positive PCR saliva sample over the course of the collection of the survey. The PUMF contains select demographic information including sex at birth, age group, province and the week of collection. The file also contains SARS-CoV-2 whole genome sequences and its associated data.
    Release date: 2023-05-25

  • Table: 13-10-0866-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.
    Release date: 2023-03-27

  • Public use microdata: 13-25-0007
    Description:

    This public use microdata file (PUMF) contains data for a wide variety of variables collected from the Canadian COVID-19 Antibody and Health Survey (CCAHS). The CCAHS collected information on the presence of chronic conditions, self-reported COVID-19 status, testing history, risk for infection, health behaviours, vaccination status and intentions to get vaccinated. COVID-19 antibody seroprevalence laboratory data, and select demographic information are also available. Survey data were collected between November 2020 and April 2021, with the vast majority of collection occurring in January and February 2021.

    Release date: 2022-11-16

  • Table: 13-10-0818-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description:

    Seroprevalence of Canadians aged 1 and older with antibodies against SARS-CoV-2 (the virus that causes COVID-19), overall and by antibody type, by age group and sex.

    Release date: 2021-07-06
Tables (5)

Tables (5) ((5 results))

  • Table: 82-570-X
    Geography: Province or territory
    Description: The Health of Canadians report brings together important health data, both for the population overall and for specific groups, to provide a comprehensive portrait of population health and to shed light on health disparities. It includes key statistics on population health such as health outcomes (e.g., chronic conditions), health behaviours (e.g., exercise, nutrition), access to health care (e.g., unmet health care needs) and determinants of health (e.g., age, income).

    The Health of Canadians report is meant to be used by our federal, provincial and territorial partners, as well as health professionals, researchers, and policymakers across the country to inform policies and plans, leading to better, more equitable health outcomes for all Canadians.
    Release date: 2025-03-05

  • Table: 13-10-0867-01
    Geography: Canada
    Frequency: Occasional
    Description: Long term symptoms were defined as having COVID-19 symptoms at least 3 months after a self-reported positive test or suspected SARS-CoV-2 infection. Results on the status of long-term symptoms only included respondents for whom a period of three months separated their self-reported date of infection and the date they completed the questionnaire.
    Release date: 2023-08-03

  • Table: 13-10-0868-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.
    Release date: 2023-08-03

  • Table: 13-10-0866-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.
    Release date: 2023-03-27

  • Table: 13-10-0818-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description:

    Seroprevalence of Canadians aged 1 and older with antibodies against SARS-CoV-2 (the virus that causes COVID-19), overall and by antibody type, by age group and sex.

    Release date: 2021-07-06
Profiles of a community or region (0)

Profiles of a community or region (0) (0 results)

No content available at this time.

Thematic maps (0)

Thematic maps (0) (0 results)

No content available at this time.

Public use microdata (3)

Public use microdata (3) ((3 results))

  • Public use microdata: 13-25-0011
    Description: This public use microdata file (PUMF) contains data for a wide variety of variables collected from the Canadian COVID-19 Antibody and Health Survey (CCAHS). The CCAHS collected information on the presence of chronic conditions, self-reported COVID-19 status, testing history, risk for infection, health behaviours and vaccination status. COVID-19 antibody seroprevalence laboratory data, and select demographic information are also available. Survey data were collected between April 2022 and August 2022, with the vast majority of collection occurring in May, June and July 2022.
    Release date: 2024-11-14

  • Public use microdata: 13-25-0009
    Description: This public use microdata file (PUMF) provides researchers access to data on the distribution of SARS-CoV-2 lineages detected in the Canadian provinces between May and September 2022. Samples were collected as part of the Canadian COVID-19 Antibody and Health Survey (CCAHS), Cycle 2. The PUMF file consists of a subset of participants of the CCAHS who submitted a positive PCR saliva sample over the course of the collection of the survey. The PUMF contains select demographic information including sex at birth, age group, province and the week of collection. The file also contains SARS-CoV-2 whole genome sequences and its associated data.
    Release date: 2023-05-25

  • Public use microdata: 13-25-0007
    Description:

    This public use microdata file (PUMF) contains data for a wide variety of variables collected from the Canadian COVID-19 Antibody and Health Survey (CCAHS). The CCAHS collected information on the presence of chronic conditions, self-reported COVID-19 status, testing history, risk for infection, health behaviours, vaccination status and intentions to get vaccinated. COVID-19 antibody seroprevalence laboratory data, and select demographic information are also available. Survey data were collected between November 2020 and April 2021, with the vast majority of collection occurring in January and February 2021.

    Release date: 2022-11-16
Data Visualization (0)

Data Visualization (0) (0 results)

No content available at this time.

Date modified: